3D C-Vit model improves tumor grading accuracy in 340 pediatric brain tumor cases
This retrospective cohort review analyzed 340 cases of pediatric brain tumors, comprising 143 low-grade and 197 high-grade cases. The study compared a 3D C-Vit model, which integrates Channel Attention-Enhanced Feature Fusion, Multi-Scale Feature Extraction, and Multi-Head Self-Attention mechanisms, against a clinical model and various radiomics models including SVM.
The 3D C-Vit model demonstrated superior performance with an AUC of 91.36%, accuracy (ACC) of 86.53%, precision of 89.29%, and an F1-score of 89.29%. Specific module contributions included a 6.92% ACC increase from the CAEFF module, an 11.67% ACC increase from the MSFE module, and a 1.64% ACC increase from the MHSA module. The CAEFF module also contributed a 6.79% AUC increase, the MSFE module contributed an 11.14% AUC increase, and the MHSA module contributed a 1.66% AUC increase. LASSO regression screened 59 key features.
Safety and tolerability data were not reported, as adverse events, serious adverse events, discontinuations, and tolerability metrics were not applicable or recorded in this computational model evaluation. The study provides clinicians with a reliable preoperative tumor grading tool, which is helpful for quickly formulating precise individualized treatment plans. However, because this is a retrospective cohort review of a computational model, the results reflect algorithmic performance rather than direct patient outcomes, and clinical application requires further validation.